Hypertension due to chronic blockade of P1-purinoceptors

Journal of Autonomic Pharmacology

Volumn 16, Issue 6, 1996, Pages 367-370

  Guimaraes S ^a   Albino Teixeira, A ^a  

^a Inst of Pharmacol and Therapeutics   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIPROPYL 8 SULPHOPHENYLXANTHINE; 8 PHENYLTHEOPHYLLINE; ADENOSINE; ADENOSINE RECEPTOR; ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; BRIMONIDINE; CAPTOPRIL; CLONIDINE; ETHYLKETAZOCINE; ISOPRENALINE; NORADRENALIN; PHENYLISOPROPYLADENOSINE; POSTSYNAPTIC RECEPTOR; PRESYNAPTIC RECEPTOR; PURINE P1 RECEPTOR ANTAGONIST; RENIN; SALBUTAMOL; UNCLASSIFIED DRUG; YOHIMBINE;

ADRENERGIC TRANSMISSION; ARTERY INTIMA PROLIFERATION; CONFERENCE PAPER; HYPERTENSION; LONG TERM EXPOSURE; MORPHOLOGY; NONHUMAN; NORADRENALIN RELEASE; PLASMA RENIN ACTIVITY; RAT;

EID: 0030425769     PISSN: 01441795     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-8673.1996.tb00055.x     Document Type: Conference Paper

References (27)

1. ALBINO-TEIXEIRA, A., MATIAS, A., POLONIA, J. & AZEVEDO, I. (1991). Blockade of adenosine receptors causes hypertension and cardiovascular structural changes in the rat. J. Hypertens., 9(suppl), S19A-S197.
2. ALBINO-TEIXEIRA, A. & OSSWALD, W. (1994). Influence of ACE-inhibition on hypertension caused by long-lasting infusion of an antagonist of adenosine receptors. J. Auton. Pharmacol., 14, 13.
3. 2-autoreceptor blockade. Br. J. Pharmacol., 90, 403-412.
4. BARCHOWSKI, A., DATA, J.L. & WHORTON, A.R. (1987). Inhibition of renin release by analogues of adenosine in rabbit renal cortical slices. Hypertension, 9, 619-623.
5. BROD, J., FENCI, V., HEJI, Z. & JIRKA, J. (1959). Circulatory changes underlying blood pressure elevation during acute emotional stress (mental arithmetic) in normotensive and hypertensive subjects. Clin. Sci., 18, 269-279.
6. EIKENBURG, D.C., & APPARSUNDARAM, S. (1992). Endogenous adenosine inhibits β-adrenoceptor facilitation of sympathetic neurotransmission. Abstracts. Stichting 7th Int. Catecholamine Symposium (Amsterdam), p. 81.
7. ENERO, A.M. & SAIDMAN, B.Q. (1977). Possible feed-back inhibition of noradrenaline release by purine compounds. Naunyn-Schmiedeberg's Arch. Pharmacol., 297, 39-46.
8. FOLKOW, B., HALLBACK, M., LUNDGREN, Y. & WEISS, L. (1970). Structurally based increase in flow resistance in spontaneously hypertensive rats. Acta Physiol. Scand., 79, 373-378.
9. GRAHAM, J.D.P. (1945). High blood pressure after a battle. Lancet, 1, 239-240.
10. 2-adrenoceptor-mediated effects at pre- but not at postjunctional level. Naunyn-Schmiedeberg's Arch. Pharmacol., 350, 692-695.
11. GUIMARAÉS, S., ALBINO-TEIXEIRA, A. & PAIVA, M.Q. (1995). Hypertension and enhanced β-adrenoceptor-mediated facilitation of noradrenaline release produced by chronic blockade of adenosine receptors. Br. J. Pharmacol., 114, 1595-1598.
12. + and glutamate-evoked release of endogenous adenosine from rat cortical slices. J. Neurochem., 54, 256-263.
13. ITOH, S., CARRETERO, O.A. & MURRAY, R.D. (1985). Possible role of adenosine in the macula densa mechanism of renin release in rabbits. J. Clin. Invest., 76, 1412-1417.
14. JACKISCH, R., FEHR, R. & HERTTING, G. (1985). Adenosine: an endogenous modulator of hippocampal noradrenaline release. Neuropharmacology, 24, 499-507.
15. JACKSON, E.K. (1991). Adenosine: a physiological brake on renin release. Annu. Rev. Pharmacol. Toxicol., 31, 1-35.
16. KAROON, P., RUBINO, A. & BURNSTOCK, G. (1995). Hypertension induced by 1,3-dipropyl-8-sulfo-phenylxanthine (DPSPX): Effects on sympathetic neurotransmission in the rat tail artery. Br. J. Pharmacol., 114(Suppl), 399P.
17. KUAN, C-J., WELLS, J.N. & JACKSON, F.K. (1990). Endogenous adenosine restrains renin release in conscious rats. Circ. Res., 66, 637-646.
18. 2-adrenoceptors and opioid κ -receptors at the noradrenergic axons of rabbit brain cortex. Naunyn-Schmiedeberg's Arch. Pharmacol., 314, 167-171.
19. 1-receptor interactions on noradrenaline release in rabbit brain cortex. Naunyn-Schmiedeberg's Arch. Pharmacol., 338, 53-61.
20. MAJEWSKI, H. (1983). Modulation of norepinephrine release through activation of β-adrenoceptors. J. Anton. Pharmacol., 3, 47-60.
21. MATIAS, A., ALBINO-TEIXEIRA, A., POLONIA, J. & AZEVIDO, I. (1991). Long-term administration of 1,3-dipropyl-8-sulphophenylxanthine causes arterial hypertension. Eur. J. Pharmacol., 193, 101-104.
22. MULVANY, M.J. (1983). Do resistence vessel abnormalities contribute to the elevated blood pressure of spontaneously hypertensive rats? Blood Vessels , 20, 1-22.
23. 1-purinoceptors with 1,3-dipropyl-8-sulfo-phenylxanthine (DPSPX). Br. J. Pharmacol., 114(Suppl), 105P.
24. RUBINO A. & BURNSTOCK, G., (1995). Changes in sympathetic neurotransmission and adrenergic control of cardiac contractility during 1,3-dipropyl-8-sulfophenylxanthine-induced hypertension. J. Pharmacol. Exp. Ther., 275, 422-428.
25. SKOTT, O. & BAUMBACH, L. (1985). Effects of adenosine on renin release from isolated rat glomeruli and kidney slices. Pflügers Arch. , 404, 232-237.
26. TAGAWA, H. & VANDER, A.J. (1970). Effects of adenosine compounds on renal function and renin secretion in dogs. Circ. Res., 26, 327-338.
27. 1 receptors. Eur. J. Pharmacol., 283, 185-192.